CA2098200A1 - Polyamine drug-resin complexes - Google Patents

Polyamine drug-resin complexes

Info

Publication number
CA2098200A1
CA2098200A1 CA002098200A CA2098200A CA2098200A1 CA 2098200 A1 CA2098200 A1 CA 2098200A1 CA 002098200 A CA002098200 A CA 002098200A CA 2098200 A CA2098200 A CA 2098200A CA 2098200 A1 CA2098200 A1 CA 2098200A1
Authority
CA
Canada
Prior art keywords
drug
pharmaceutical composition
composition according
cation
exchange resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002098200A
Other languages
English (en)
French (fr)
Inventor
William Joseph Kelleher
Anthony Earl Carpanzano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2098200A1 publication Critical patent/CA2098200A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002098200A 1990-12-21 1991-12-16 Polyamine drug-resin complexes Abandoned CA2098200A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63229090A 1990-12-21 1990-12-21
US632,290 1990-12-21

Publications (1)

Publication Number Publication Date
CA2098200A1 true CA2098200A1 (en) 1992-06-21

Family

ID=24534913

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002098200A Abandoned CA2098200A1 (en) 1990-12-21 1991-12-16 Polyamine drug-resin complexes

Country Status (17)

Country Link
EP (1) EP0563294A1 (hu)
JP (1) JPH06504059A (hu)
CN (1) CN1063221A (hu)
AU (1) AU663695B2 (hu)
BR (1) BR9107173A (hu)
CA (1) CA2098200A1 (hu)
CZ (1) CZ119793A3 (hu)
FI (1) FI932842A0 (hu)
HU (1) HUT74642A (hu)
IE (1) IE914513A1 (hu)
MX (1) MX9102753A (hu)
MY (1) MY107811A (hu)
NO (1) NO932212L (hu)
NZ (1) NZ241097A (hu)
PT (1) PT99912A (hu)
SK (1) SK59493A3 (hu)
WO (1) WO1992011038A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005161A1 (en) * 1993-08-13 1995-02-23 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
JP4619457B2 (ja) * 1993-11-18 2011-01-26 シルテックス、メディカル、リミテッド 徐放性製剤
ES2097087B1 (es) * 1994-08-01 1997-12-16 Univ Sevilla Sistema de liberacion controlada de morfina y otros farmacos solubles en agua por complejacion con sustancias polimericas.
CA2269679A1 (en) * 1996-12-20 1998-07-02 Warner-Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
KR20020016069A (ko) * 2000-08-24 2002-03-04 민경윤 마크로라이드계 항생제의 경구투여용 조성물 및 이의 제조방법
MXPA06002300A (es) 2003-09-03 2006-05-19 Mallinckrodt Inc Preparacion granular de liberacion sostenida y produccion de la misma.
CN100411629C (zh) * 2006-08-28 2008-08-20 浙江大学 一种缓释型补铁剂的制备方法
CN100415297C (zh) * 2006-08-28 2008-09-03 浙江大学 基于阳离子交换树脂的锌补充剂的制备方法
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
WO2015076821A1 (en) * 2013-11-22 2015-05-28 Tris Pharma, Inc. Novel clonidine formulation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
FR2634377B1 (fr) * 1988-06-30 1991-09-27 Cortial Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes

Also Published As

Publication number Publication date
AU9168791A (en) 1992-07-22
AU663695B2 (en) 1995-10-19
BR9107173A (pt) 1993-11-16
NO932212L (no) 1993-08-20
HUT74642A (en) 1997-01-28
JPH06504059A (ja) 1994-05-12
MX9102753A (es) 1992-06-30
HU9301819D0 (en) 1993-09-28
NO932212D0 (no) 1993-06-16
EP0563294A1 (en) 1993-10-06
FI932842A (fi) 1993-06-18
PT99912A (pt) 1993-01-29
SK59493A3 (en) 1993-11-10
WO1992011038A1 (en) 1992-07-09
NZ241097A (en) 1994-11-25
FI932842A0 (fi) 1993-06-18
CN1063221A (zh) 1992-08-05
IE914513A1 (en) 1992-07-01
CZ119793A3 (en) 1994-01-19
MY107811A (en) 1996-06-29

Similar Documents

Publication Publication Date Title
EP0367746B1 (en) Sustained release drug-resin complexes
US4221778A (en) Prolonged release pharmaceutical preparations
DE112005000730B4 (de) Ionen bindende Polymere und ihre Verwendung
Guo et al. Ion-exchange resins as drug delivery carriers
US6001392A (en) Antitussive drugs delivered by ion exchange resins
CA2098200A1 (en) Polyamine drug-resin complexes
CA1236023A (en) Controlled release pharmaceutical preparations
DE112006002618T5 (de) Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers
US4859462A (en) Polymer-treated ion exchange resins
EP0254811A2 (en) Coated ion exchange resins
WO1999021586A2 (en) Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
CA1086226A (en) Ion exchange resin prolonged release pharmaceutical preparations
Borodkin Ion-exchange resin delivery systems
EP0254822A2 (en) Polymer-treated ion exchange resins
USRE28316E (en) Entrapment compositions and processes
Bajpai et al. Ion exchange resins in drug delivery
Bhumarkar et al. Formulation design and evaluation of xyloglucan microsphere of silymarin
Mhetre et al. Ion Exchange Resin: A Novel Drug Delivery System An overview
DE19619313A1 (de) Zubereitung mit retardierter Wirkstofffreisetzung

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued